Wallace Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$2.26M Buy
2019
Q3
Sell
2019
Q2
$685K Sell
2019
Q1
$663K Hold
2018
Q4
$435K Hold
2018
Q3
$634K Buy
2018
Q2
$271K Buy